Background: For patients experiencing an acute coronary syndrome (ACS), a crucial time to assess their prognosis and to plan management is at discharge from hospital.
INTRODUCTION
Secondary prevention following an acute coronary syndrome (ACS) is a crucial issue because further ischaemic events after the index event are common. Risk prediction tools have identified several risk factors for death and myocardial infarction (MI) following an ACS event [1, 2] . However, most risk scores include hospital mortality in their estimations [3] [4] [5] , and relatively little attention has been paid to risk assessment at discharge from hospital [6] . This study aimed to identify risk factors of mortality in patients up to six years after discharge following a hospitalisation for ACS.
METHODS
We performed a single-centre, prospective study of consecutive patients hospitalised for ACS between 2002 and 2004 in our Department with a 24-h catheter laboratory. All patients underwent coronary angiography and, if indicated, percutaneous coronary intervention (PCI). In total, 672 patients with non-fatal ACS, who survived until hospital discharge, were enrolled, and all of them were followed until 2009. The Third Universal Definition of Myocardial Infarction was used in our study [7] . The patients were classified as having ST-segment elevation myocardial infraction (STEMI) or unstable angina/non-ST-segment elevation myocardial infraction (UA/NSTEMI), according to current guidelines: (i) STEMI: the presence of ST-segment elevation of ≥ 0.2 mV in men aged ≥ 40 years, ≥ 0.25 mV in men aged < 40 years, ≥ 0.15 mV in women in V2-V3 leads and/or ST-segment elevation of ≥ 0.1 mV in two or more standard leads or new left bundle branch block and positive cardiac necrosis markers; and (ii) UA/NSTEMI: the presence of ST-segment depression of ≥ 0.05 mV in two or more standard leads or T-wave flattening or inversion and positive cardiac necrosis markers.
The approval of the ethical committee was obtained before initiation of the study.
Study endpoints
The primary endpoint was defined as all-cause mortality during six years of follow-up. Survival status and date of death were obtained from the National Registry Population.
Statistical analysis
We identified over 78 candidate variables for prediction (medical history on admission, during admission, and at discharge), and these are listed in Appendix 1 (see journal website). From those, the most notable risk factors for post-discharge mortality were developed using Cox proportional hazards model. The statistical approach for factor selection was backward stepwise variable elimination, with a criterion of statistical significance of 5% for variable inclusion. Statistical significance was set at p < 0.05.
Only the variables present in at least 90% of subjects listed in the registry were included in the multivariate analysis.
Statistical analysis was performed using MS Windows XP Professional, MS Office 2003 Professional, Statistica 9 PL, and SAS Software 9 (SAS Institute, Cary, NC, USA).
RESULTS
Out of 722 patients with ACS who underwent coronary angiography, 50 patients were excluded from the current analysis because of death during hospitalisation. The final study group included 672 patients (median age, 61 years [range, 52-70 years]; 448 [66.7%] men). The flow chart of patient enrolment to the study is presented in Figure 1 . A total of 417 (62.05%) patients were diagnosed with STEMI, and all of them were treated with PCI. The remaining 255 (37.95%) patients presented with UA/NSTEMI; 157 (61.57%) of these patients were treated with PCI, 42 (16.47%) were referred for coronary artery bypass grafting (CABG), and 56 (35.67%) were treated conservatively. Detailed characteristics of the STEMI and UA/NSTEMI groups are presented in Supplementary  Table S1 (see journal website) .
During the follow-up, 123 (18.3%) patients died: 75 from the STEMI group and 48 from the UA/NSTEMI group. The overall mortality assessed during the follow-up until 2009 was comparable between patients with UA/NSTEMI and STEMI (18.8% vs. 18%, p = 0.79). Detailed characteristics of patients who survived and died during the post-discharge period are presented in Table 1 .
From all the candidate variables available, the Cox proportional hazards model identified 11 highly significant independent predictors of six-year mortality ( Table 2 ). All negative predictors of post-discharge survival of patients with STEMI and UA/NSTEMI are shown in Tables 3 and 4 , respectively; the only common predictor for both groups was diabetes.
DISCUSSION
One of the most interesting results of our research is the importance of risk factors rarely reported in other studies. It is well established that age, diabetes, previous MI, time of chest pain onset, tachycardia, hypotension, cardiogenic shock, anterior wall MI, and renal function are independent predictors of poor prognosis in patients with ACS; however, in our study, the prognostic value of these factors during the post-discharge period was reduced, and other clinical parameters (male sex, peripheral vascular disease), adverse events (recurrent angina pectoris with electrocardiographic [ECG] changes, new arrhythmias during hospitalisation), or complications due to invasive treatment were shown to gain importance [8] [9] [10] [11] . This is in line with the observation from the GUSTO-I trial [8] among 1891 patients with STEMI, which aimed to assess long-term outcome and determine its predictors among 30-day survivors of cardiogenic shock. The strongest predictors of higher mortality during 11-year follow-up included age, shock, higher Killip class, cerebrovascular disease, prior MI, prior CABG, hypertension, diabetes, and anterior location of MI. Interestingly, among patients with cardiogenic shock who survived 30 days after STEMI, the annual mortality rates of 2% to 4% approximated those of patients without shock [8] . This phenomenon is defined by some authors as "the calm after the storm", analogously to an "electrical storm", which in itself can be a complication in high-risk patients [9, 12] .
Another example of the so-called "depletion" of the prognostic value of some risk factors important during the in-hospital period is a lack of statistical difference in pulse and blood pressure values between patients who survived and those who died after ACS. In a study by Eagle et al. [10] , a reduction of 20 mmHg in systolic blood pressure had a less significant prognostic value in the GRACE score for post-dis- Continuous variables are presented as median (interquartile range), and categorical variables are presented as absolute numbers (percentages). P values are given for differences between the ST-segment elevation myocardial infraction (STEMI) and the unstable angina/non-ST-segment elevation myocardial infraction (UA/NSTEMI) patients. Conversion factors to SI units are as follows: for total cholesterol -0.0259; HDL-C -0.0259; LDL-C -0.0259; triglicerydes -0.0113; troponin I -1.0. ACE -angiotensin-converting-enzyme; ASA -acetylsalicylic acid; CABG -coronary artery bypass grafting; CI -confidence interval; COPD -chronic obstructive pulmonary disease; CK-MB -creatinine kinase-MB; CRP -C reactive protein; DBP -diastolic blood pressure; ECG -electrocardiography; eGFR -estimated glomerular filtration rate; GP -glycoprotein; HDL-C -high-density lipoprotein cholesterol; HR -hazard ratio; IABP -intra-aortic balloon pump; LAD -left anterior descending artery; LBBB -left bundle branch block; LCx -left circumflex artery; LDL-C -low-density lipoprotein cholesterol; LM -left main coronary artery; LMWH -low molecular weight heparin; MDRD -glomerular filtration rate using the Modification of Diet in Renal Disease Study equation; MI -myocardial infarction; MV-CAD -multivessel coronary artery disease; NA -non-applicable; NYHA -New York Heart Association; PCI -percutaneous coronary intervention; POBA -plain old balloon angioplasty; PVD -peripheral vascular disease; RBBB -right bundle branch block; RCA -right coronary artery; SCA -sudden cardiac arrest; SBP -systolic blood pressure; TIMI -thrombolysis in myocardial infarction; UFH -unfractionated heparin 19 ). In addition, an increase in heart rate of more than 30 bpm had prognostic value only in in-hospital evaluation of the GRACE score (HR 1.30; 95% CI 1.23-1.47) [10] .
The importance of heart rate may vary depending on the assessment period, but also on the range of heart rate. A study by Bangalore et al. [13] evaluated 139,194 patients with UA/NSTEMI in the CRUSADE quality improvement initiative. Patients with systolic blood pressure lower than 90 mmHg (4030 patients) were excluded to avoid the confounding effect of cardiogenic shock. An adjusted OR was calculated using a reference OR of 1 for a heart rate of 60 to 69 bpm, after controlling for baseline variables. Compared with a reference group, patients with higher heart rate on presentation had up to a 2.2-fold increased risk of all-cause mortality and up to 1.9-fold increased risk of stroke. There was a J-shaped relationship between presenting heart rate and in-hospital primary outcome, all-cause mortality, and stroke, such that the event rates increased at both high and very low heart rate. However, there was no J-shaped relationship between presenting heart rate and risk of re-infarction [13] .
An example of the risk factors differentiating STEMI and UA/NSTEMI populations is the type of biochemical myocardial necrosis marker -creatine kinase-MB (CK-MB) for patients with STEMI and troponin I for those with NSTEMI. This can be explained by the characteristics of a given indicator. In the STEMI population, where the markers of myocardial necrosis concentrations are higher, dynamic changes of CK-MB correlate better with the extent of myocardial damage and the effectiveness of reperfusion therapy than troponins. However, in patients with UA/NSTEMI, in whom the most important is the biochemical confirmation of MI, troponin I showed higher sensitivity for predicting mortality.
Another risk factor with a different prognostic value for patients with STEMI and NSTEMI in our analysis was the type of arrhythmias that occurred during hospitalisation. In the multivariate model, an important prognostic indication in patients with STEMI was supraventricular arrhythmias (relative risk [RR] 3.5), whereas in patients with UA/NSTEMI it was ventricular arrhythmias (RR 8.9). Our observations of the relationship between prognosis and occurrence of ventricular arrhythmias in UA/NSTEMI are consistent with reports from the GRACE registry. In the registry, the proportion of patients who developed ventricular arrhythmias during hospitalisation was 6.9% (1.8% with ventricular tachycardia [VT], 5.1% with ventricular fibrillation or cardiac arrest). Patients with STEMI were more likely to have ventricular arrhythmias (12%) than those with NSTEMI (4.9%) or UA (3.1%, p < 0.001). Several demographic and clinical variables were associated with the occurrence of ventricular arrhythmias, including ST-segment deviation, Killip class, age, initial cardiac markers, serum creatinine level, heart rate, and history of selected comorbidities. Ventricular arrhythmias during hospitalisation for ACS were associated with higher in-hospital mortality in the whole study group (OR 46.5, 95% CI 40.7-52.9) as well as in the STEMI and UA/NSTEMI subgroups (OR 31.8, 95% CI 26.7-27.8 and OR 80.8, 95% CI 65.8-99.2), with a higher impact observed in patients with UA/NSTEMI. Nevertheless, the adverse effect of ventricular arrhythmias on the prognosis for up to six months after discharge, excluding in-hospital mortality, was only significant in the UA/NSTEMI group (OR 1.46, 95% CI 1.01-2.10), and not in the STEMI group (OR 1.29; 95% CI 0.96-1.75) [14] . These results are in line with our findings. Moreover, the rates of ventricular arrhythmias without sudden cardiac arrest (SCA) and with resuscitated SCA were 3% and 3.9%, respectively. The frequency of ventricular arrhythmias was higher in the STEMI group than in the UA/NSTEMI group, with a significant difference in resuscitated SCA (5.3% vs. 1.6%, p = 0.0156) and no significant difference in ventricular arrhythmias without SCA (3.8% vs. 1.6%, p = 0.0931) [13] . Recent studies indicate that milder forms of ventricular arrhythmia may also be important in patients with UA/NSTEMI. The MERLIN-TIMI 36 trial [15] confirmed that non-sustained VT is common in patients with NSTEMI, and even short episodes of VT lasting from four to seven beats are independently associated with the risk of sudden cardiac death (SCD) during the subsequent year. A total of 6345 (97%) patients had continuous ECG recordings evaluable for analysis. Compared with patients with no VT (n = 2764), there was no increased risk of SCD in patients with only ventricular triplets (n = 1978, 31.2%; 1.4% vs. 1.2%); however, the risk of SCD was higher in patients with VT lasting from four to seven beats (n = 1172, 18.5%; SCD 2.9%, adjusted HR 2.3, p < 0.001) and in patients with VT lasting at least eight beats (n = 431, 6.8%; SCD 4.3%, adjusted HR 2.8, p = 0.001). This effect was independent of baseline characteristics and ejection fraction. VT occurring within the first 48 h after admission was not associated with SCD [15] .
Other interesting clinical prognostic parameters are recurrence of angina pectoris with ischaemia on ECG for the UA/NSTEMI group and hospital discharge for the STEMI group. In the case of angina pectoris with ischaemia on ECG, this indicator may reflect two clinical situations. First, it can identify patients enrolled in the first hours of the conservative strategy who had recurrence of pain, and second, it identifies patients who have not undergone PCI due to advanced coronary lesions or while awaiting cardiac surgery for angina pectoris with ischaemic changes. This situation is probably more common in the UA/NSTEMI group than the STEMI group, so this factor was identified in the model. Hospital discharge as a risk factor in the NSTEMI group can be explained by the fact that those patients were more likely to be referred to cardiac surgery departments due to complications of ACS (myocardial rupture, coronary artery perforation), to the co-operating departments of medicine for longer follow-up and optimisation of pharmacotherapy, or referred for CABG surgery.
Because the main purpose of the study was to assess the long-term outcome of patients with ACS hospitalised and discharged from a particular referral centre with 24-h catheter laboratory in collaboration with centres without an interventional cardiology unit, this was a single-centre study. Such analysis may be more appropriate than the use of clinical trial data, which initially represents the population excluding the most at-risk patients.
The smaller number of patients with UA/NSTEMI is also a limitation for statistical analysis. On the other hand, regarding the purpose of the study, data for the whole population seem to be largely useful and universal.
Another limitation is no division of the ACS group without persistent ST-segment elevation into UA and NSTEMI subgroups. It is well-known that the UA subgroup has a better prognosis. However, given the common definition of these populations in the standards for the diagnosis and treatment of ACS, and the fact that the UA group is a minority, especially in reference centres to which patients are referred for interventional treatment, the common denotation of these populations is, in our opinion, useful in practice. It should also be noted that the distinction between UA and NSTEMI patients would be very difficult due to the data collection period, especially between 2002 and 2003 when the new division of ACS was introduced into practice.
Another limitation is the fact that the data obtained from the PESEL database did not provide an opportunity to analyse the causes of death. It was also impossible to provide data on the occurrence of non-fatal complications.
In conclusion, we documented marked differences in the risk of post-discharge mortality after an ACS event. The risk factors obtained both from the medical history and during the hospitalisation increased the power of the risk stratification model.
